Brazilian Journal of Anesthesiology
https://bjan-sba.org/article/doi/10.1590/S0034-70942010000200003
Brazilian Journal of Anesthesiology
Scientific Article

Anestesia espinhal com 10 mg de bupivacaína hiperbárica associada a 5 µg de sufentanil para cesariana: estudo de diferentes volumes

Spinal Block with 10 mg of hyperbaric bupivacaine associated with 5 µg of sufentanil for cesarean section: study of different volumes

Angélica de Fátima de Assunção Braga; José Aristeu Fachini Frias; Franklin Sarmento da Silva Braga; Daniela Roncoletta da Silva Pinto

Downloads: 2
Views: 1113

Resumo

JUSTIFICATIVA E OBJETIVOS: Diversos fatores influenciam na dispersão cefálica da solução anestésica no espaço subaracnóideo, entre os quais destacam-se as alterações fisiológicas inerentes à gravidez, baricidade, dose e volume do anestésico local. O objetivo deste estudo foi avaliar em cesarianas a efetividade e os efeitos colaterais de diferentes volumes da associação de bupivacaína hiperbárica e sufentanil por via subaracnóidea. MÉTODO: Quarenta pacientes, ASA I e II, submetidas à cesariana eletiva sob raquianestesia distribuídas em dois grupos, de acordo com o volume da solução anestésica empregada: Grupo I (4 mL) e Grupo II (3 mL). Nos dois grupos o anestésico local empregado foi a bupivacaína hiperbárica (10 mg-2 mL) associada ao sufentanil (5 µg-1 mL). No Grupo I, para obtenção do volume de 4 mL, foi adicionado 1 mL de solução fisiológica a 0,9%. Foram avaliados: latência do bloqueio; nível máximo do bloqueio sensitivo; grau do bloqueio motor; tempo para regressão do bloqueio motor; duração total da analgesia; efeitos adversos maternos e repercussões neonatais. RESULTADOS: A latência, o nível máximo do bloqueio sensitivo, o grau e o tempo para regressão do bloqueio motor foram semelhantes nos dois grupos; a duração da analgesia foi maior no Grupo I, com diferença significativa em relação ao Grupo II. Os efeitos adversos ocorreram com frequência semelhante em ambos os grupos. Ausência de alterações cardiocirculatórias maternas e repercussões neonatais. CONCLUSÕES: A bupivacaína hiperbárica na dose de 10 mg associada ao sufentanil na dose de 5 µg, com volume de 4 mL, foi mais eficaz que a mesma associação em menor volume (3 mL), proporcionando melhor analgesia intra e pós-operatória, sem repercussões materno-fetais.

Palavras-chave

ANESTÉSICO, Local, CIRURGIA, Obstétrica, TÉCNICAS ANESTÉSICAS, Regional

Abstract

BACKGROUND AND OBJECTIVES: Several factors affect the cephalad dispersion of the anesthetic solution in the subarachnoid space; among them, physiological changes of pregnancy and the dose and volume of the local anesthetics should be mentioned. The objective of this study was to assess the effectivity and side effects of different volumes of the subarachnoid administration of the association of hyperbaric bupivacaine and sufentanil in cesarean sections. METHODS: Forty patients, ASA I and II, undergoing elective cesarean section under spinal block were divided in two groups, according to the volume of the anesthetic solution: Group I (4 mL) and Group II (3 mL). The association of hyperbaric bupivacaine (10 mg-2 mL) and sufentanil (5 µg-1 mL) was used in both groups. In Group I, 1 mL of NS was added to the solution to achieve the volume of 4 mL. The following parameters were evaluated: latency of the blockade; upper limit of the sensorial blockade; degree of motor blockade; time for regression of the motor blockade; total duration of analgesia; maternal side effects; and neonatal repercussions. RESULTS: Latency, the upper limit of the sensorial blockade, and the degree and time for regression of the motor blockade were similar in both groups; duration of analgesia was greater in Group I than in Group II, which was statistically significant. The incidence of side effects was similar in both groups. Maternal cardiocirculatory changes and neonatal repercussions were not observed. CONCLUSIONS: Four milliliter of anesthetic solution composed of hyperbaric bupivacaine, 10 mg, associated with 5 µg of sufentanil was more effective than 3 ml of the same solution, providing better intra-and postoperative analgesia without maternal-fetal repercussions.

Keywords

ANESTHETIC, Local, ANESTHETIC TECHNIQUE, Regional, SURGERY, Obstetric

Referencias

Dyer RA, Joubert IA. Low-dose spinal anaesthesia for Caesarean section. Curr Opin Anaesthesiol. 2004;17:301-308.

Mathias RS, Carvalho JCA. Anestesia regional para Cesárea. Rev Bras Anestesiol. 1993;43:43-56.

Greene NM. Distribuition of local anesthetic solutions within the subarachnoid space. Anesth Analg. 1985;64:715-730.

Strienstra R, Greene NM. Factors affecting the subarachnoid spread of local anesthesic solutions. Reg Anesth. 1991;16:1-6.

Strienstra R, Veering BT. Intratechal drug spread: is it controllable?. Reg Anesth Pain Med. 1998;23:347-351.

Chung CJ, Bae SH, Chae KY. Spinal anaesthesia with 0,25% hyperbaric bupivacaine for Caesarean section: effects of volume. Br J Anaesth. 1996;77:145-149.

Dahlgren G, Hultstrand C, Jakobsson J. Intrathecal sufentanil, fentanyl, or placebo added to bupivacaine for cesarean section. Anesth Analg. 1997;85:1288-1293.

Choi DH, Ahn HJ, Kim MH. Bupivacaine-sparing effect of fentanyl in spinal anesthesia for cesarean delivery. Reg Anesth Pain Med. 2000;25:240-245.

Braga AF, Braga FS, Potério GM. Sufentanil added to hyperbaric bupivacaine for subarachnoid block in Caesarean section. Eur J Anaesthesiol. 2003;20:631-635.

Bromage PR. A comparasion of the hydrochloride and carbon dioxide salts of lidocaine and prilocaine in epidural analgesia. Acta Anaesthesiol Scand. 1965;16(^sSuppl):55-69.

Pedersen H, Santos AC, Steinberg ES. Incidence of visceral pain during cesarean section: the effect of varying doses of bupivacaine. Anesth Analg. 1989;69:46-49.

Hallworth SP, Fernando R, Columb MO. The effect of posture and baricity on the spread of intrathecal bupivacaine for elective cesarean delivery. Anesth Analg. 2005;100:1159-1165.

Simon L, Boulay G, Ziane AF. Effect of injection rate on hypotension associated with spinal anesthesia for cesarean section. Int J Obstet Anaesth. 2000;9:10-14.

McLeod GA. Density of spinal anaesthetic solutions of bupivacaine, levobupivacaine and ropivacaine with and without dextrose. Br J Anaesth. 2004;92:547-551.

Richardson MG, Wissler RN. Density of lumbar cerebrospinal fluid in pregnant e nonpregnant humans. Anesthesiology. 1996;85:326-330.

Imbelloni LE, Moreira AD, Gaspar FC. Avaliação da densidade dos anestésicos locais e da combinação com adjuvantes: Estudo em laboratório. Rev Bras Anestesiol. 2009;59:154-165.

Connolly C, McLeod GA, Wildsmith JAW. Spinal anaesthesia for Caesarean section with bupivacaine 5 mg.ml-1 in glucose 8 or 80 mg.ml-1. Br J Anaesth. 2001;86:805-807.

Hare GMT, Ngan JCS. Density determination of local anaesthetic opioid mixtures of spinal anaesthesia. Can J Anaesth. 1998;45:341-346.

Cangiani LM. Determinação da densidade e da baricidade das misturas para anestesia subaracnóidea. Rev Bras Anestesiol. 2000;50:92-94.

Balki M, Carvalho JCA. Intraoperative nausea and vomiting during cesarean section under regional anesthesia. Int J Obstet Anaesth. 2005;14:230-241.

Kiran S, Singal NK. A comparative study of three different doses of 0.5% hyperbaric bupivacaine for spinal anaesthesia in elective caesarean section. Int J Obstet Anaesth. 2002;11:185-189.

Malinovsky JM, Renaud G, Le Corre P. Intrathecal bupivacaine in humans: influence of volume and baricity of solutions. Anesthesiology. 1999;91:1260-1266.

5dd2e27e0e88256621c63493 rba Articles
Links & Downloads

Braz J Anesthesiol

Share this page
Page Sections